From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease
Authors
Keywords
-
Journal
MOLECULES
Volume 27, Issue 13, Pages 4292
Publisher
MDPI AG
Online
2022-07-05
DOI
10.3390/molecules27134292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
- (2022) Yuto Unoh et al. JOURNAL OF MEDICINAL CHEMISTRY
- An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
- (2022) Bao-Xue Quan et al. Nature Microbiology
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Search for Non-Protein Protease Inhibitors Constituted with an Indole and Acetylene Core
- (2021) Marco A. Almaraz-Girón et al. MOLECULES
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
- (2020) Wioletta Rut et al. Nature Chemical Biology
- Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals
- (2020) Daniel W. Kneller et al. STRUCTURE
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Synthesis and Process Optimization of Boceprevir: A Protease Inhibitor Drug
- (2014) Dinesh S. Bhalerao et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- 3C Protease of Enterovirus 68: Structure-Based Design of Michael Acceptor Inhibitors and Their Broad-Spectrum Antiviral Effects against Picornaviruses
- (2013) J. Tan et al. JOURNAL OF VIROLOGY
- JLigand: a graphical tool for theCCP4 template-restraint library
- (2012) Andrey A. Lebedev et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDSAPP: a graphical user interface for the convenient processing of diffraction data usingXDS
- (2012) Michael Krug et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
- (2012) Keith P. Romano et al. PLoS Pathogens
- An introduction to data reduction: space-group determination, scaling and intensity statistics
- (2011) Philip R. Evans ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Picornavirus non-structural proteins as targets for new anti-virals with broad activity
- (2011) Heléne Norder et al. ANTIVIRAL RESEARCH
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Molecular replacement withMOLREP
- (2009) Alexei Vagin et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters
- (2008) Koen H.G. Verschueren et al. CHEMISTRY & BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now